Dr Reddy's Q3 Results Preview: Profit may drop on Lower Revl

The drugmaker is expected to report a 1.1% YoY drop in consolidated net profit to Rs 1,247 crore, according to the average of estimates given by seven brokerages. The company is scheduled to release its quarterly earnings on Tuesday.

Related Keywords

United States , India , China , Russia , America , , North America , Rdrl , Drl Shares , Drl Q3 Review , Dr Reddy Rsquos Q3 Preview , Dr Reddy Rsquos Q3 Results Preview ,